Saturn V Capital Management LLC Astria Therapeutics, Inc. Transaction History

Saturn V Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.42 - $8.06 $1.01 Million - $1.84 Million	-228,430 Reduced 18.74%	990,663 $7.61 Billion
Q3 2023 Nov 14, 2023	BUY	$6.89 - $9.86 $4 Million - $5.73 Million	581,236 Added 91.12%	1,219,093 $9.09 Billion
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $4.47 Million - $7.36 Million	536,518 Added 529.43%	637,857 $5.31 Billion
Q1 2023 May 15, 2023	SELL	$11.2 - $15.79 $763,324 - $1.08 Million	-68,154 Reduced 40.21%	101,339 $1.35 Billion
Q4 2022 Feb 09, 2023	BUY	$7.44 - $14.89 $1.26 Million - $2.52 Million	169,493 New	169,493 $1.56 Billion

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $150M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Saturn V Capital Management LLC with notifications on news.